Sartorius Stedim (Germany) Analysis

56S1 Stock  EUR 178.10  1.45  0.82%   
Sartorius Stedim Biotech is overvalued with Real Value of 153.86 and Hype Value of 178.1. The main objective of Sartorius Stedim stock analysis is to determine its intrinsic value, which is an estimate of what Sartorius Stedim Biotech is worth, separate from its market price. There are two main types of Sartorius Stedim's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Sartorius Stedim's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Sartorius Stedim's stock to identify patterns and trends that may indicate its future price movements.
The Sartorius Stedim stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Sartorius Stedim's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sartorius Stedim Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Sartorius Stock Analysis Notes

About 74.0% of the company shares are owned by insiders or employees . The company has Price/Earnings (P/E) ratio of 110.44. Sartorius Stedim Biotech recorded earning per share (EPS) of 9.32. The entity last dividend was issued on the 30th of March 2023. The firm had 6:1 split on the 6th of May 2016. Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. SARTOR STED operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8200 people. For more info on Sartorius Stedim Biotech please contact Joachim Kreuzburg at 33 4 42 84 56 00 or go to https://www.sartorius.com.

Sartorius Stedim Biotech Investment Alerts

Sartorius Stedim had very high historical volatility over the last 90 days
About 74.0% of the company shares are owned by insiders or employees

Sartorius Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 28.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sartorius Stedim's market, we take the total number of its shares issued and multiply it by Sartorius Stedim's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Sartorius Profitablity

Sartorius Stedim's profitability indicators refer to fundamental financial ratios that showcase Sartorius Stedim's ability to generate income relative to its revenue or operating costs. If, let's say, Sartorius Stedim is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Sartorius Stedim's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Sartorius Stedim's profitability requires more research than a typical breakdown of Sartorius Stedim's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.25 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.32 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.32.

Technical Drivers

As of the 27th of November, Sartorius Stedim has the Coefficient Of Variation of 5461.36, risk adjusted performance of 0.0218, and Semi Deviation of 2.34. Sartorius Stedim technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices. Please validate Sartorius Stedim Biotech variance, jensen alpha, and the relationship between the standard deviation and information ratio to decide if Sartorius Stedim is priced more or less accurately, providing market reflects its prevalent price of 178.1 per share.

Sartorius Stedim Biotech Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Sartorius Stedim middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Sartorius Stedim Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Sartorius Stedim Outstanding Bonds

Sartorius Stedim issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Sartorius Stedim Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Sartorius bonds can be classified according to their maturity, which is the date when Sartorius Stedim Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Sartorius Stedim Predictive Daily Indicators

Sartorius Stedim intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Sartorius Stedim stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Sartorius Stedim Forecast Models

Sartorius Stedim's time-series forecasting models are one of many Sartorius Stedim's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Sartorius Stedim's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Sartorius Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Sartorius Stedim prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Sartorius shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Sartorius Stedim. By using and applying Sartorius Stock analysis, traders can create a robust methodology for identifying Sartorius entry and exit points for their positions.
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG. SARTOR STED operates under Medical Instruments Supplies classification in Germany and is traded on Frankfurt Stock Exchange. It employs 8200 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Sartorius Stedim to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Complementary Tools for Sartorius Stock analysis

When running Sartorius Stedim's price analysis, check to measure Sartorius Stedim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sartorius Stedim is operating at the current time. Most of Sartorius Stedim's value examination focuses on studying past and present price action to predict the probability of Sartorius Stedim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sartorius Stedim's price. Additionally, you may evaluate how the addition of Sartorius Stedim to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
CEOs Directory
Screen CEOs from public companies around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas